Loading…

Innospec Inc.IOSPCompetitor analysis, valuation and peers

United States · USD·Materials›Chemicals: Major Diversified

Makes specialty chemicals for fuel additives, performance chemicals and personal care/oilfield applications.

Momentum weak 34
Mkt cap
$1.94B
US dollars, full cap
Free float
98%
of shares outstanding
$/day
$23.4M
20-day average traded
Fwd P/E
13.8×
forward earnings
ROIC−WACC
+1.3 pp
WACC 9.3%
Hurdle
-3 pp
Req g minus delivered
Next earnings
85 days
11 Feb 2027
Close · USD$78.86
1D+1.1%
1W+0.7%
1M-20.5%
3M-15.1%
6M+0.2%
YTD+3.0%
1Y+9.2%
ATR %3.3%
Beta0.38
52w lowhigh22.7% off high

What Innospec does

Makes specialty chemicals for fuel additives, performance chemicals and personal care/oilfield applications.

Sells additives that refiners and fuel distributors dose into petrol and diesel to improve performance and meet quality standards, so sales follow fuel volumes and regional specifications. Personal-care ingredients and oilfield chemicals add two different markets: one tied to consumer brands' formulation work, the other to drilling and production activity.

Products and services

  • Fuel additives (performance, octane)
  • Personal care ingredients
  • Oilfield services chemicals

Customers

  • Fuel refiners/blenders
  • Personal care product manufacturers
  • Oilfield service companies

Where it sits in the supply chain

  • Materials
  • Chemicals: Major Diversified
  • Specialty and fuel additive chemicals

What could go right

  • Personal care ingredient demand growth
  • Fuel additive demand in emerging markets

What could go wrong

  • Declining gasoline/ICE fuel volumes long term
  • Oilfield services cyclicality

Moat: narrow (IP / patents, process know-how). Proprietary fuel additive formulations and personal care ingredient chemistry serve niche, technical markets.

Headquarters: Englewood, Colorado, US · Founded: 1938 · Employees: 2,450

Named competitors

Innospec at a glance

Size Innospec (IOSP) is a United States Materials company (Chemicals: Major Diversified) with a market value of $1.94B, the 1793rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $78.86 on 18 Nov 2026.

Performance Over six months the shares gained 0.2%, against -14.8% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 20 in its peer set.

Growth Revenue grew 4.7% over the last twelve months (peer median +11.3%); the operating margin is 8.5% (peer median 11.1%).

Valuation It trades at 13.8× forward earnings against a peer median of 23.5× (5th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.3 points above its cost of capital (9.3% WACC).

Short interest Short interest is 1.9% of the free float (30 Oct 2026).

Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026IOSP 100Peer median 84
Six months, rebased to 100: Innospec against the median of its 20 peers (local-currency closes).

Innospec financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.87B$1.78B$1.85B$1.95B$1.96B
Revenue growth—-4%-5%-1%—
Gross profit$518M$482M$533M$583M$575M
EBITDA$204M$206M$229M$212M$232M
Net income$140M$117M$35.6M$139M$133M
Free cash flow$46.6M$88.0M$143M$144M$42.1M
Capital expenditure$68.7M$75.5M$62.3M$77.2M$42.3M
Total debt$47.3M$52.7M$44.9M$45.2M$45.3M

Quarterly statements and history in the cockpit →

Innospec competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%-10%0%+10%47491717NGVT688545002326FINEORGAARTIIND42724114457190002643AETHERHUNBRGPRIVISCL688549014680300596IOSP6-month return →1-month return →
Up and to the right = strong over both horizons. Innospec is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%20×40×60×80×47491717NGVT688545FINEORGAARTIIND4272ACT0002643AETHERBRGPRIVISCL300910IOSPRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Innospec is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%10%20%30%1717NGVTFINEORG4272ACT0002643BRGPRIVISCL300910014680IOSPGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Innospec is the large dot.

Innospec competitors and peer comparison

Head to head with its named competitors (IOSP vs NEU vs CRDA.L vs CLN.SW)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Innospec IOSP$1.94B0%+5%8%13.8×5.0%
NewMarket NEU$6.47B-1%+1%20%n/a-0.2%
Croda International CRDA.L$7.07B+29%+3%16%24.2×21.0%
Clariant CLN.SW$4.20B+35%-7%10%16.3×-3.3%

How Innospec compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Innospec against its 20 peers (data as of 18 Nov 2026)
MeasureIOSPPeer medianRank in peer set
1-month return-20.5%-8.2%3rd lowest of 21
6-month return+0.2%-14.8%6th highest of 20
Distance from 52-week high-22.7%-33.9%8th highest of 21
Revenue growth (TTM)+4.7%+11.3%4th lowest of 21
Operating margin8.5%11.1%6th lowest of 21
Forward P/E13.8×23.5×5th cheapest of 17
Growth the price implies (Req g, 7 yrs)5.0%3.9%6th least demanding of 11
Growth delivered (Del g)+8.3%+7.5%4th highest of 11
Hurdle (Req g minus delivered)-3.3 pp-1.1 pp5th least demanding of 11
ROIC minus cost of capital+1.3 pp-0.3 pp9th highest of 21
EV / EBITDA8.6×13.5×3rd cheapest of 13
Net debt / EBITDA-1.0×1.2×3rd least indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Innospec IOSPUnited States$1.94B0%+5%8%13.8×5.0%+8.3%
Advanced Echem Materials 4749.TWOTaiwan$1.93B-34%+20%25%33.6×n/an/a
Eternal Materials 1717.TWTaiwan$1.96B-29%+7%6%14.8×14.5%+1.2%
Ingevity NGVTUnited States$1.97B-12%-12%26%10.2×-1.4%-0.8%
Hubei Sinophorus Electronic Materials 688545.SSChina$2.07B-39%+75%11%62.9×n/an/a
Zhejiang Yongtai Technology 002326.SZChina$1.81B-44%+38%11%n/an/an/a
Fine Organic Industries FINEORG.NSIndia$1.81B+21%+13%20%33.4×28.7%+15.7%
AARTI Industries AARTIIND.NSIndia$1.80B-1%+40%9%29.9×n/an/a
Nippon Kayaku 4272.TJapan$1.71B-9%+16%10%10.5×1.7%+6.9%
Nippon Shokubai 4114.TJapan$2.24B+16%+8%6%17.4×n/an/a
Alzchem ACT0.DEGermany$1.68Bn/a+5%16%23.1×0.5%+8.2%
Isuspecialtychemical 457190.KSSouth Korea$1.62B-32%+6%2%n/an/an/a
Valiant 002643.SZChina$1.61B-36%+3%10%26.1×17.1%+4.9%
Aether Industries AETHER.NSIndia$2.34B+50%+31%25%76.6×n/an/a
Huntsman HUNUnited States$1.58B-36%+6%0%n/an/an/a
Borregaard BRG.OLNorway$1.58B+6%+3%17%24.0×-1.2%+7.7%
Privi Speciality Chemicals PRIVISCL.NSIndia$1.44B+11%+18%20%36.4×30.6%+15.0%
Grandit 688549.SSChina$2.66B-7%+40%-1%n/an/an/a
Xinxiang Richful Lube Additive 300910.SZChina$1.36B-33%+12%16%12.2×2.1%+32.5%
Hanchem 014680.KSSouth Korea$1.35B-49%+11%17%11.6×5.8%+7.4%
Rianlon 300596.SZChina$1.35B-15%+11%11%14.2×n/an/a

Questions

Who are Innospec's main competitors?
Named competitors: NewMarket (Afton Chemical) (NEU), Croda International (CRDA.L), Clariant (CLN.SW). The cockpit's measured peer set (industry) also includes Advanced Echem Materials (4749.TWO), Eternal Materials (1717.TW), Ingevity (NGVT), Hubei Sinophorus Electronic Materials (688545.SS), Zhejiang Yongtai Technology (002326.SZ), Fine Organic Industries (FINEORG.NS).
Is Innospec expensive compared with its peers?
On forward p/e it trades at 13.8× against a peer median of 23.5×, 5th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Innospec stock performed?
Over six months to 18 Nov 2026 the shares returned +0.2% against -14.8% for the median peer; over one year +9.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.